Scholarlink

<p>Phospholipidosis (PLD) is the excessive accumulation of phospholipids within cells, which is, for example, observed in the liver following exposure to certain chemicals or drugs. Although the precise molecular mechanisms underlying PLD remain incompletely elucidated, it is documented that PLD is frequently induced by cationic amphiphilic compounds. To facilitate the identification of potential PLD inducers across diverse groups of chemicals, the development of novel high-throughput screening methodologies is imperative. Here, an <i>in vitro</i> human liver cell culture system was established for PLD screening, employing the fluorescence-based LipidTox assay in differentiated HepaRG cells in a&#xa0;96-well format. Cells were treated with a selection of 35 compounds characterized as either PLD inducers or non-inducers, based on previously published <i>in vivo</i> data. Concentration-response curves of phospholipid accumulation were assessed and the results were compared with existing <i>in vivo, in vitro</i> and <i>in silico</i> datasets. The findings confirm the applicability of the LipidTOX assay in differentiated HepaRG cells as a reliable <i>in vitro</i>-based high-throughput screening method for PLD prediction, achieving an overall predictivity of 86%.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

New approach methodologies for metabolic disruption: a high-throughput human liver cell phospholipidosis assay

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月10日

查看全文
  • Neele Wewer,
  • Albert Braeuning,
  • Dajana Lichtenstein

摘要

Phospholipidosis (PLD) is the excessive accumulation of phospholipids within cells, which is, for example, observed in the liver following exposure to certain chemicals or drugs. Although the precise molecular mechanisms underlying PLD remain incompletely elucidated, it is documented that PLD is frequently induced by cationic amphiphilic compounds. To facilitate the identification of potential PLD inducers across diverse groups of chemicals, the development of novel high-throughput screening methodologies is imperative. Here, an in vitro human liver cell culture system was established for PLD screening, employing the fluorescence-based LipidTox assay in differentiated HepaRG cells in a 96-well format. Cells were treated with a selection of 35 compounds characterized as either PLD inducers or non-inducers, based on previously published in vivo data. Concentration-response curves of phospholipid accumulation were assessed and the results were compared with existing in vivo, in vitro and in silico datasets. The findings confirm the applicability of the LipidTOX assay in differentiated HepaRG cells as a reliable in vitro-based high-throughput screening method for PLD prediction, achieving an overall predictivity of 86%.